Fresenius US Finance to redeem $300 million 4.5% notes Dec. 13

By Mary-Katherine Stinson

Lexington, Ky., Dec. 1 – Fresenius US Finance II, Inc. announced it will redeem its $300 million 4.5% notes due 2023 (ISIN: US35804GAK40, USU31436AH86) on Dec. 13, according to a notice.

The Rule 144A and Regulation S notes will be redeemed in full at par plus accrued interest to the redemption date, totaling a redemption price of $2,037 per note.

Bank of New York Mellon London Branch is the paying agent.

Fresenius US Finance II, Inc. operates as a health care company. The company provides wide range of drugs, nutritional products, medical devices, and services for dialysis, hospitals, and outpatient treatment and serves customers in the United States and Europe.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.